EUVIMEDEUVIMED entdecken
Crossref

Dual activation of autophagy and mTOR by TFE3 fusions promotes tumorigenesis in rearranged renal cell carcinoma

Ruina Wu iD, Xiaotong Wang, Miaomiao Tian, Xue Wei, Xuan Wang, Shengbing Ye, Rusong Zhang, Qiuyuan Xia, Ru Fang iD, Qiu Rao iD

Carcinogenesis · 2025

DOI: 10.1093/carcin/bgaf080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Carcinogenesis, 2025. Verfasst von Ruina Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jinling Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210023, China. Hauptthemen laut MEDLINE: Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Carcinoma, Renal Cell, TOR Serine-Threonine Kinases, Kidney Neoplasms. Die Arbeit nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Scientific Research Project of Jiangsu Health Commission, National Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TFE3-rearranged renal cell carcinoma (TFE3-RCC), an aggressive kidney cancer predominantly affecting pediatric and young adult populations, is driven by Xp11.2 rearranged generating oncogenic TFE3 fusion proteins. Although these fusions define the disease, their mechanistic roles remain elusive. Here, lentiviral-mediated overexpression of PRCC-TFE3 or NONO-TFE3 in RCC models triggered nuclear rearranged fusion proteins and significantly accelerated tumor proliferation both in vitro and in vivo. Our integrated RNA sequencing (RNA-seq) and chromatin immunoprecipitation sequencing (ChIP-seq) analyses mechanistically revealed that TFE3 fusions directly bind to promoters of lysosome and mTOR signaling pathway genes, leading to transcriptional activation of this pathway. Moreover, the fusions aberrantly escaped canonical mTOR signaling pathway regulation and paradoxically hyperactivated phospho-mTOR signaling. Importantly, dual inhibition of the autophagy and mTOR pathways synergistically suppressed tumor growth, exceeding the efficacy of single-agent treatments. These data demonstrate that co-targeting these TFE3-regulated pathways represents a promising therapeutic strategy for this intractable malignancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basic Helix-Loop-Helix Leucine Zipper Transcription FactorsCarcinoma, Renal CellTOR Serine-Threonine KinasesKidney NeoplasmsAutophagyOncogene Proteins, FusionHumansAnimalsMiceSignal TransductionCell ProliferationGene Expression Regulation, NeoplasticCarcinogenesisCell Line, Tumor

Stichwörter der Autor:innen

TFE3 fusion proteinTFE3-rearranged renal cell carcinomaautophagymTOR signaling pathway

Substanzen

Basic Helix-Loop-Helix Leucine Zipper Transcription FactorsTOR Serine-Threonine KinasesTFE3 protein, humanMTOR protein, humanOncogene Proteins, Fusion

Autor:innen und Institutionen

  • Jinling Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210023, China.
  • Department of Pathology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210002, China.

ORCID-Profile: Ruina Wu, Ru Fang, Qiu Rao

Förderung

  • National Natural Science Foundation of China
  • Scientific Research Project of Jiangsu Health Commission
  • National Natural Science Foundation of Jiangsu Province

Zitieren

APA

Wu, R., Wang, X., Tian, M., Wei, X., Wang, X., Ye, S., Zhang, R., Xia, Q., Fang, R., & Rao, Q. (2025). Dual activation of autophagy and mTOR by TFE3 fusions promotes tumorigenesis in rearranged renal cell carcinoma. Carcinogenesis. https://doi.org/10.1093/carcin/bgaf080

Vancouver

Wu R, Wang X, Tian M, Wei X, Wang X, Ye S, et al. Dual activation of autophagy and mTOR by TFE3 fusions promotes tumorigenesis in rearranged renal cell carcinoma. Carcinogenesis. 2025. doi:10.1093/carcin/bgaf080

BibTeX
@article{Wu2025,
  author = {Wu, Ruina and Wang, Xiaotong and Tian, Miaomiao and Wei, Xue and Wang, Xuan and Ye, Shengbing and Zhang, Rusong and Xia, Qiuyuan and Fang, Ru and Rao, Qiu},
  title = {Dual activation of autophagy and mTOR by TFE3 fusions promotes tumorigenesis in rearranged renal cell carcinoma},
  journal = {Carcinogenesis},
  year = {2025},
  doi = {10.1093/carcin/bgaf080}
}
Kostenlos starten →